Movano (NASDAQ:MOVE – Get Free Report) and Aspyra (OTCMKTS:APYI – Get Free Report) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.
Valuation and Earnings
This table compares Movano and Aspyra”s revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Movano | $1.01 million | 6.13 | -$23.73 million | ($40.69) | -0.18 |
Aspyra | N/A | N/A | N/A | N/A | N/A |
Profitability
This table compares Movano and Aspyra’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Movano | -4,302.13% | -359.83% | -203.15% |
Aspyra | N/A | N/A | N/A |
Insider & Institutional Ownership
16.6% of Movano shares are held by institutional investors. 21.1% of Movano shares are held by insiders. Comparatively, 23.9% of Aspyra shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Risk and Volatility
Movano has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, Aspyra has a beta of 1.91, meaning that its share price is 91% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of current ratings and target prices for Movano and Aspyra, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Movano | 1 | 0 | 0 | 0 | 1.00 |
Aspyra | 0 | 0 | 0 | 0 | 0.00 |
Summary
Aspyra beats Movano on 5 of the 8 factors compared between the two stocks.
About Movano
Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.
About Aspyra
Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices. The company was formerly known as Creative Computer Applications Inc. and changed its name to Aspyra Inc. in November 2005. Aspyra Inc. was founded in 1978 and is headquartered in Jacksonville, Florida.
Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.